Back to Search Start Over

Extended release of adenovirus from silica implants in vitro and in vivo.

Authors :
Kangasniemi, L.
Koskinen, M.
Jokinen, M.
Toriseva, M.
Ala-Aho, R.
Kähäri, V.-M.
Jalonen, H.
Ylä-Herttuala, S.
Moilanen, H.
Stenman, U.-H.
Diaconu, I.
Kanerva, A.
Pesonen, S.
Hakkarainen, T.
Hemminki, A.
Source :
Gene Therapy. Jan2009, Vol. 16 Issue 1, p103-110. 8p. 1 Color Photograph, 1 Chart, 3 Graphs.
Publication Year :
2009

Abstract

Despite promising preclinical results, the clinical benefits of cancer gene therapy have been modest heretofore. The main obstacle continues to be the level and persistence of gene delivery to sufficiently large areas of the tumor. One approach for overcoming this might entail extended local virus release. We studied the utility of silica gel monoliths for delivery of adenovirus to advanced orthotopic gastric and pancreatic cancer tumors. Initially, the biochemical properties of the silica-virus matrix were studied and nearly linear release as a function of time was detected. Virus stayed infective for weeks at +37 °C and months at +4 °C, which may facilitate storage and distribution. In vivo, extended release of functional replication deficient and also replication-competent, capsid-modified oncolytic viruses was seen. Treatment of mice with pancreatic cancer doubled their survival (P<0.001). Also, silica gel-based delivery slowed the development of antiadenovirus antibodies.Gene Therapy (2009) 16, 103–110; doi:10.1038/gt.2008.142; published online 28 August 2008 [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09697128
Volume :
16
Issue :
1
Database :
Academic Search Index
Journal :
Gene Therapy
Publication Type :
Academic Journal
Accession number :
35972992
Full Text :
https://doi.org/10.1038/gt.2008.142